DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 3,030.00
+50.00 (1.68%)
May 21, 2026, 3:30 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 95.31 billion as of May 21, 2026. Its market cap has decreased by -40.87% in one year.
Market Cap
95.31B
Enterprise Value
127.04B
Revenue
130.34B
Ranking
n/a
PE Ratio
10.85
Stock Price
3,030.00
Market Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 95.31B, a decrease of -52.43%. That is a compound annual growth rate of -44.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 95.31B | -18.58% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.16T |
| Celltrion | 38.40T |
| ALTEOGEN | 19.13T |
| Samsung Epis Holdings | 12.35T |
| CKD Bio | 99.30B |
| Sugentech | 98.77B |
| iNtRON Biotechnology | 97.53B |
| Humasis | 95.39B |